According to Core Scientific's latest financial reports the company has $50.4 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $50.4 M | 217.36% |
2022-12-31 | $15.88 M | -86.52% |
2021-12-31 | $0.11 B | 1259.37% |
2020-12-31 | $8.67 M | 30.25% |
2019-12-31 | $6.65 M |